The clinical relevance of APOL3 in CRC was also assessed from TCGA data, mRNA expression of APOL3 down-regulated in CRC tissues (P<0.001) and low expression of APOL3 statistically correlates with more lymph node metastasis and distant metastasis (Figure S6). Here, APOL3 is linked to colorectal carcinoma.